• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Potentially inappropriate medications based on TIME criteria and risk of in-hospital mortality in COVID-19 patients.基于 TIME 标准的潜在不适当药物与 COVID-19 患者住院死亡率的关系。
Rev Assoc Med Bras (1992). 2022 Nov 28;68(12):1730-1736. doi: 10.1590/1806-9282.20220907. eCollection 2022.
2
Analysis of potentially inappropriate medications (PIM) used in elderly outpatients in departments of internal medicine by using the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) criteria.使用老年人潜在不适当处方筛查工具(STOPP)标准分析内科老年门诊患者中使用的潜在不适当药物(PIM)。
Ann Palliat Med. 2021 Apr;10(4):4678-4686. doi: 10.21037/apm-21-799.
3
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients.老年 COVID-19 住院患者中的多种药物治疗、潜在不适当用药和药物-药物相互作用。
BMC Geriatr. 2023 Nov 25;23(1):774. doi: 10.1186/s12877-023-04487-9.
4
Prevalence and predictors of inappropriate prescribing according to the Screening Tool of Older People's Prescriptions and Screening Tool to Alert to Right Treatment version 2 criteria in older patients discharged from geriatric and internal medicine wards: A prospective observational multicenter study.老年患者从老年医学和内科病房出院后,根据老年人用药评估工具和适宜药物治疗筛查工具 2 版标准评估的不适当处方的流行率及其预测因素:一项前瞻性观察性多中心研究。
Geriatr Gerontol Int. 2019 Jan;19(1):5-11. doi: 10.1111/ggi.13542. Epub 2018 Oct 11.
5
Potentially Inappropriate Prescribing in Disabled Older Patients with Chronic Diseases: A Screening Tool of Older Persons' Potentially Inappropriate Prescriptions versus Beers 2012 Criteria.患有慢性病的残疾老年患者中潜在不适当处方情况:老年人潜在不适当处方筛查工具与《2012年Beers标准》对比
Med Princ Pract. 2015;24(6):565-70. doi: 10.1159/000435955. Epub 2015 Aug 1.
6
Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study.不适当处方定义为 STOPP 和 START 标准,及其与住院老年患者药物不良事件的关系:一项多中心、前瞻性研究。
PLoS One. 2019 Jul 26;14(7):e0219898. doi: 10.1371/journal.pone.0219898. eCollection 2019.
7
Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study.泰国老年患者潜在不适当用药情况及住院率:一项回顾性队列研究。
Eur J Clin Pharmacol. 2022 May;78(5):847-855. doi: 10.1007/s00228-021-03269-9. Epub 2022 Jan 29.
8
Potentially inappropriate medications in Chinese older adults: The beers criteria compared with the screening tool of older persons' prescriptions criteria.中国老年人潜在不适当用药:比尔斯标准与老年人用药筛选工具标准比较。
Geriatr Gerontol Int. 2017 Nov;17(11):1951-1958. doi: 10.1111/ggi.12999. Epub 2017 Feb 22.
9
Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.社区老年人群队列中的肾功能、多重用药及潜在不适当用药情况
Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.
10
A prevalence study of potentially inappropriate medications use in hospitalized Pakistani elderly.一项针对巴基斯坦住院老年患者潜在不适当药物使用的流行性病学研究。
Aging Clin Exp Res. 2018 Jan;30(1):53-60. doi: 10.1007/s40520-017-0742-7. Epub 2017 Mar 3.

引用本文的文献

1
Cross-Cultural Adaptation and Clinical Validation of TIME Criteria to Detect Potentially Inappropriate Medication Use in Older Adults: Methodological Report from the TIME International Study Group.用于检测老年人潜在不适当用药的TIME标准的跨文化适应与临床验证:TIME国际研究小组的方法学报告
Drugs Aging. 2025 Jan;42(1):57-67. doi: 10.1007/s40266-024-01164-3. Epub 2024 Dec 17.
2
Potentially inappropriate medication as a predictor of poor prognosis of COVID-19 in older adults: a South Korean nationwide cohort study.潜在不适当用药作为老年人新冠病毒病预后不良的预测因素:一项韩国全国队列研究
BMJ Open. 2024 Jul 17;14(7):e073367. doi: 10.1136/bmjopen-2023-073367.
3
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients.老年 COVID-19 住院患者中的多种药物治疗、潜在不适当用药和药物-药物相互作用。
BMC Geriatr. 2023 Nov 25;23(1):774. doi: 10.1186/s12877-023-04487-9.

本文引用的文献

1
The Johns Hopkins University Center for Systems Science and Engineering COVID-19 Dashboard: data collection process, challenges faced, and lessons learned.约翰斯·霍普金斯大学系统科学与工程中心 COVID-19 数据仪表盘:数据收集流程、面临的挑战和经验教训。
Lancet Infect Dis. 2022 Dec;22(12):e370-e376. doi: 10.1016/S1473-3099(22)00434-0. Epub 2022 Aug 31.
2
Nutrition risk assessed by Nutritional Risk Screening 2002 is associated with in-hospital mortality in older patients with COVID-19.营养风险筛查 2002 评估的营养风险与 COVID-19 老年患者的院内死亡率相关。
Nutr Clin Pract. 2022 Jun;37(3):605-614. doi: 10.1002/ncp.10860. Epub 2022 Apr 30.
3
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability.预测 COVID-19 住院老年患者的死亡风险:COVID-19 死亡率评分与虚弱和残疾的比较。
J Am Med Dir Assoc. 2021 Aug;22(8):1588-1592.e1. doi: 10.1016/j.jamda.2021.05.028. Epub 2021 Jul 2.
4
International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study.国际验证土耳其老年人不适当用药(TIME)标准集:德尔菲小组研究。
Drugs Aging. 2021 Jun;38(6):513-521. doi: 10.1007/s40266-021-00855-5. Epub 2021 Apr 13.
5
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients.药物-药物相互作用和出院时的处方适宜性:COVID-19 患者的经验。
Drugs Aging. 2021 Apr;38(4):341-346. doi: 10.1007/s40266-021-00840-y. Epub 2021 Mar 1.
6
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.老年 COVID-19 住院患者院内死亡的临床特征和预测因素。
Age Ageing. 2021 Feb 26;50(2):326-334. doi: 10.1093/ageing/afaa258.
7
Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.药物-药物相互作用和 COVID-19 患者的处方适宜性:来自意大利北部参考医院的回顾性分析。
Drugs Aging. 2020 Dec;37(12):925-933. doi: 10.1007/s40266-020-00812-8. Epub 2020 Nov 5.
8
Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation.快速 COVID-19 严重程度指数的制定与验证:一种用于早期临床失代偿的预后工具。
Ann Emerg Med. 2020 Oct;76(4):442-453. doi: 10.1016/j.annemergmed.2020.07.022. Epub 2020 Jul 21.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.COVID-SAFER:老年人羟氯喹药物相互作用的减药指导。
J Am Geriatr Soc. 2020 Aug;68(8):1636-1646. doi: 10.1111/jgs.16623. Epub 2020 Jun 30.

基于 TIME 标准的潜在不适当药物与 COVID-19 患者住院死亡率的关系。

Potentially inappropriate medications based on TIME criteria and risk of in-hospital mortality in COVID-19 patients.

机构信息

Marmara University, Faculty of Medicine, Department of Internal Medicine, Division of Geriatrics - Pendik (Istanbul), Turkey.

Marmara University, Faculty of Medicine, Department of Chest Diseases and Intensive Care - Pendik (Istanbul), Turkey.

出版信息

Rev Assoc Med Bras (1992). 2022 Nov 28;68(12):1730-1736. doi: 10.1590/1806-9282.20220907. eCollection 2022.

DOI:10.1590/1806-9282.20220907
PMID:36449802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9779964/
Abstract

OBJECTIVE

This study aimed to evaluate the relationship between hospital admission potentially inappropriate medications use (PIM) and in-hospital mortality of COVID-19, considering other possible factors related to mortality.

METHODS

The Turkish inappropriate medication use in the elderly (TIME) criteria were used to define PIM. The primary outcome of this study was in-hospital mortality.

RESULTS

We included 201 older adults (mean age 73.1±9.4, 48.9% females). The in-hospital mortality rate and prevalence of PIM were 18.9% (n=38) and 96% (n=193), respectively. The most common PIM according to TIME to START was insufficient vitamin D and/or calcium intake per day. Proton-pump inhibitor use for multiple drug indications was the most prevalent PIM based on TIME to STOP findings. Mortality was related to PIM in univariate analysis (p=0.005) but not in multivariate analysis (p=0.599). Older age (hazards ratio (HR): 1.08; 95% confidence interval (CI): 1.02-1.13; p=0.005) and higher Nutritional Risk Screening 2002 (NRS-2002) scores were correlated with in-hospital mortality (HR: 1.29; 95%CI 1.00-1.65; p=0.042).

CONCLUSION

Mortality was not associated with PIM. Older age and malnutrition were related to in-hospital mortality in COVID-19.

摘要

目的

本研究旨在评估 COVID-19 住院患者潜在不适当药物使用(PIM)与院内死亡率之间的关系,同时考虑其他可能与死亡率相关的因素。

方法

使用土耳其老年人不适当药物使用(TIME)标准来定义 PIM。本研究的主要结局为院内死亡率。

结果

我们纳入了 201 名老年人(平均年龄 73.1±9.4 岁,48.9%为女性)。院内死亡率和 PIM 的发生率分别为 18.9%(n=38)和 96%(n=193)。根据 TIME 开始标准,最常见的 PIM 是每日摄入不足的维生素 D 和/或钙。根据 TIME 停止标准,质子泵抑制剂用于多种药物适应证是最常见的 PIM。在单因素分析中,死亡率与 PIM 相关(p=0.005),但在多因素分析中不相关(p=0.599)。年龄较大(风险比(HR):1.08;95%置信区间(CI):1.02-1.13;p=0.005)和较高的营养风险筛查 2002 评分(NRS-2002)与院内死亡率相关(HR:1.29;95%CI 1.00-1.65;p=0.042)。

结论

死亡率与 PIM 无关。年龄较大和营养不良与 COVID-19 患者的院内死亡率相关。